Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Nivolumab improves overall survival for advanced kidney cancer

Prof Padmanee Sharma - MD Anderson Cancer Center, Houston, USA
Nivolumab improves overall survival for advanced kidney cancer ( Prof Padmanee Sharma - MD Anderson Cancer Center, Houston, USA )
26 Sep 2015

Predicting progression and survival in CLL

Prof Jonathan Strefford - University of Southampton, Southampton, UK
Predicting progression and survival in CLL ( Prof Jonathan Strefford - University of Southampton, Southampton, UK )
9 Sep 2015

Expert panel discussion: The best of iwCLL 2015

Prof John Gribben, Prof Michael Hallek, Dr Michael Keating, Prof Kanti Rai
Expert panel discussion: The best of iwCLL 2015 ( Prof John Gribben, Prof Michael Hallek, Dr Michael Keating, Prof Kanti Rai )
9 Sep 2015

Epidemiology of CLL: Interlymph consortium and genome-wide sequencing studies

Prof Claire Vajdic - University of New South Wales, Sydney, Australia
Epidemiology of CLL: Interlymph consortium and genome-wide sequencing studies ( Prof Claire Vajdic - University of New South Wales, Sydney, Australia )
8 Sep 2015

Translational research and the future of CLL treatment

Prof Steven Coutré – Stanford University School of Medicine, Stanford, USA
Translational research and the future of CLL treatment ( Prof Steven Coutré – Stanford University School of Medicine, Stanford, USA )
7 Sep 2015

Mapping the relationship between genetics and the impact of aspirin on colorectal cancer

Dr Hongmei Nan – Indiana University–Purdue University Indianapolis, Indiana, USA
Mapping the relationship between genetics and the impact of aspirin on colorectal cancer ( Dr Hongmei Nan – Indiana University–Purdue University Indianapolis, Indiana, USA )
3 Sep 2015

Why doesn’t aspirin protect everyone from colorectal cancer?

Dr Hongmei Nan – Indiana University–Purdue University Indianapolis, Indiana, USA
Why doesn’t aspirin protect everyone from colorectal cancer? ( Dr Hongmei Nan – Indiana University–Purdue University Indianapolis, Indiana, USA )
2 Sep 2015

Conference overview: Aspirin in the 21st Century

Prof Peter Rothwell – The University of Oxford, Oxford, UK
Conference overview: Aspirin in the 21st Century ( Prof Peter Rothwell – The University of Oxford, Oxford, UK )
2 Sep 2015

Aspirin for cancer treatment and prevention

Prof Peter Elwood – Cardiff University, Cardiff, UK
Aspirin for cancer treatment and prevention ( Prof Peter Elwood – Cardiff University, Cardiff, UK )
2 Sep 2015

Understanding the intricacies of platelet activation and inhibition

Prof Carlo Patrono – Catholic University School of Medicine, Rome, Italy
Understanding the intricacies of platelet activation and inhibition ( Prof Carlo Patrono – Catholic University School of Medicine, Rome, Italy )
2 Sep 2015

Mechanisms behind bleeding with aspirin

Prof Angel Lanas – University Hospital Zaragoza, Zaragoza, Spain
Mechanisms behind bleeding with aspirin ( Prof Angel Lanas – University Hospital Zaragoza, Zaragoza, Spain )
2 Sep 2015

Effects of aspirin on colorectal cancer

Dr Farhat Din – University of Edinburgh, Edinburgh, UK
Effects of aspirin on colorectal cancer ( Dr Farhat Din – University of Edinburgh, Edinburgh, UK )
2 Sep 2015